Biological Evaluation of 8-Methoxy-2,5-dimethyl-5H-indolo[2,3-b] Quinoline as a Potential Antitumor Agent via PI3K/AKT/mTOR Signaling
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242015142 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yunhao Ma und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Lanzhou University, 199 Donggang West Road, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Colorectal Neoplasms, Quinolines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Research and Development Program of Gansu Province, the Technological Innovation Guidance Program of Gansu Province, Technology Program of Lanzhou City.
Abstract (Originalsprache)
Chemotherapy is commonly used clinically to treat colorectal cancer, but it is usually prone to drug resistance, so novel drugs need to be developed continuously to treat colorectal cancer. Neocryptolepine derivatives have attracted a lot of attention because of their good cytotoxic activity; however, cytotoxicity studies on colorectal cancer cells are scarce. In this study, the cytotoxicity of 8-methoxy-2,5-dimethyl-5H-indolo[2,3-b] quinoline (MMNC) in colorectal cells was evaluated. The results showed that MMNC inhibits the proliferation of HCT116 and Caco-2 cells, blocks the cell cycle in the G2/M phase, decreases the cell mitochondrial membrane potential and induces apoptosis. In addition, the results of western blot experiments suggest that MMNC exerts cytotoxicity by inhibiting the expression of PI3K/AKT/mTOR signaling pathway-related proteins. Based on these results, MMNC is a promising lead compound for anticancer activity in the treatment of human colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Lanzhou University, 199 Donggang West Road, Lanzhou 730000, China.
- Faculty of Applied Science, Macao Polytechnic University, Macao, China.
ORCID-Profile: Huanxiang Liu, Peng Chen
Förderung
- the Key Research and Development Program of Gansu Province
- the Technological Innovation Guidance Program of Gansu Province
- Technology Program of Lanzhou City
- Medical Innovation and Development Project of Lanzhou University
- the College Students' Innovation and Entrepreneurship Program of Lanzhou University, China
- Innovation and Entrepreneurship Training Program of Lanzhou University, China
- the College Students’ Innovation and Entrepreneurship Program of Lanzhou University, China
Zitieren
APA
Ma, Y., Zhu, H., Jiang, X., Zhou, Z., Zhou, Y., Tian, Y., Zhang, H., Sun, M., Tu, L., Lu, J., Niu, Y., Liu, H., Liu, Y., & Chen, P. (2023). Biological Evaluation of 8-Methoxy-2,5-dimethyl-5H-indolo[2,3-b] Quinoline as a Potential Antitumor Agent via PI3K/AKT/mTOR Signaling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242015142
Vancouver
Ma Y, Zhu H, Jiang X, Zhou Z, Zhou Y, Tian Y, et al. Biological Evaluation of 8-Methoxy-2,5-dimethyl-5H-indolo[2,3-b] Quinoline as a Potential Antitumor Agent via PI3K/AKT/mTOR Signaling. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242015142
BibTeX
@article{Ma2023,
author = {Ma, Yunhao and Zhu, Hongmei and Jiang, Xinrong and Zhou, Zhongkun and Zhou, Yong and Tian, Yanan and Zhang, Hao and Sun, Mengze and Tu, Lixue and Lu, Juan and Niu, Yuqing and Liu, Huanxiang and Liu, Yingqian and Chen, Peng},
title = {Biological Evaluation of 8-Methoxy-2,5-dimethyl-5H-indolo[2,3-b] Quinoline as a Potential Antitumor Agent via PI3K/AKT/mTOR Signaling},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242015142}
}
EUVIMED